Inotuzumab Biosimilar - Research Grade
Product Specifications
Product Name Alternative
CAT-8015, GCR-8015, HA22, (sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14
Host
CHO Cells
Reactivity
Human
Target
CD22
Isotype
IgG4 κ
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using Protein A
Concentration
5mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH2861
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Specificity
Detects human CD22
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
Bulk Human IgG4 Isotype Control (IB4) [ICH2257]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Hepatitis B Surface Antigen, ad, ay (HBsAg) (MaxLight 650) discontinued
DEFB107A (Beta-Defensin 107, Beta-Defensin 7, BD-7, DEFB-7, Defensin, beta 107, DEFB107A, DEFB107, DEFB7) (AP)
DEFB107A (Beta-Defensin 107, Beta-Defensin 7, BD-7, DEFB-7, Defensin, beta 107, DEFB107A, DEFB107, DEFB7) (AP)
